This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
ADCETRIS 50 mg, poudre pour solution à diluer pour perfusion
INN: BRENTUXIMAB VÉDOTINE
Data updated: 2026-04-11
Available in:
🇩🇪🇬🇧🇫🇷
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
TAKEDA PHARMA (DANEMARK) (FR)
Source
BDPM_FR
(
ARTG
)
Hodgkin lymphoma,Treatment of patients with previously untreated CD30+ Stage III or Stage IV Hodgkin lymphoma (HL) in combination with doxorubicin, vinblastine, and dacarbazine (AVD).,Treatment of adult patients with previously untreated CD30+ Stage IIB with large mediastinal mass and/or extranodal disease, Stage III or Stage IV HL in combination with etoposide, cyclophosphamide, doxorubicin, dacarbazine, dexamethasone (BrECADD).,Treatment of adult patients with CD30+ HL at higher risk of relapse or progression following ASCT.,Treatment of adult patients with relapsed or refractory CD30+ HL:,1. following autologous stem cell transplant (ASCT) or,2. following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option.
Peripheral T-cell lymphoma,Treatment of adult patients with previously untreated CD30+ peripheral T-cell lymphoma (PTCL) in combination with cyclophosphamide, doxorubicin, and prednisone (CHP).,Treatment of adult patients with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL).,Cutaneous T cell lymphoma,Treatment of adult patients with CD30+ cutaneous T-cell lymphoma (CTCL) after at least 1 prior systemic therapy.
